Absci Corporation (ABSI) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research • Thursday
Absci Reports Business Updates and Third Quarter 2026 Financial and Operating ResultsGlobeNewsWire • Thursday
Absci Appoints Gerry Muhle as Chief Commercial Officer to Build Category-Defining Brands for ABS-201 and Its Broader PipelineGlobeNewsWire • Thursday
Absci Corporation (ABSI) Presents at 3rd Annual Guggenheim Healthcare Innovation Conference TranscriptSeeking Alpha • Wednesday
Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026GlobeNewsWire • 10/13/26
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for EndometriosisGlobeNewsWire • 09/24/26
Absci Corporation (ABSI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/16/26
AMD's $1.3 Billion Portfolio Reveals Its Biggest Investments and Where AI Demand Lands Next24/7 Wall Street • 08/18/26
4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes PharmaZacks Investment Research • 08/17/26
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating ResultsGlobeNewsWire • 08/11/26
Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026GlobeNewsWire • 07/14/26
Wall Street Analysts Predict a 28.3% Upside in ABSCI CORP (ABSI): Here's What You Should KnowZacks Investment Research • 07/13/26
Here's Why Absci Corporation (ABSI) is a Great Momentum Stock to BuyZacks Investment Research • 07/02/26
ABSI Soars 36% on Positive Interim Update From Phase I Hair Loss StudyZacks Investment Research • 06/25/26
ABSCI CORP (ABSI) Soars 36.0%: Is Further Upside Left in the Stock?Zacks Investment Research • 06/25/26
Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis ProgramBenzinga • 06/24/26
Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial InvestorsGlobeNewsWire • 06/24/26